Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen

Fig. 1

Comparison of ECAS absolute outcome scores of patients with SMA type 2 and 3 before treatment initiation (V0)

A, B, C: Box plots of the ALS-specific domains in patients with SMA type 2 compared to patients with SMA type 3. D, E: Box plots of the non-ALS-specific domains in patients with SMA type 2 compared to patients with SMA type 3. F, G: Box plots of ECAS subscores in patients with SMA type 2 compared to patients with SMA type 3. H: Boxplot of ECAS total score in patients with SMA type 2 compared to patients with SMA type 3. ALS: amyotrophic lateral sclerosis; ECAS: Edinburgh Cognitive and Behavioral ALS Screen; SMA: spinal muscular atrophy. Box plots show median (horizontal line), inter-quartile range (boxes) and scores outside of inter-quartile range (whiskers). Calculated by Mann-Whitney U-test. Significance levels: ** p < 0.01; ns: statistically not significant.

Back to article page